Tagged with Healthcare,

Portugal One of Europe’s smaller nations and its westernmost, Portugal, with a pharma market worth roughly USD 3.5 billion, may not be known as the continent’s pharma powerhouse. Yet the country boasts plenty of impressive credentials —such as a national healthcare system (NHS) that is not only universal and free, but…

Spain A roundup of the latest news from Spanish pharma, including Almirall’s licensing deal with EpimAb Biotherapeutics; the opening of Insud Pharma’s oligonucleotides centre in India, and Esteve Química’s new FDA-cleared manufacturing site.   Almirall licenses bispecific platform in $210m EpimAb deal (BioProcess International) EpimAb Biotherapeutics has out-licensed the rights for…

Morocco With a generational universal healthcare reform underway in Morocco, the country’s Minister of Health and Social Protection Khalid Aït Taleb outlines why the ongoing updates to his country’s healthcare system far outweigh what has gone before in terms of scale and scope. Minister Aït Taleb also touches on digitalisation and…

Morocco The Moroccan National Social Security Fund (CNSS) has taken on a transformational mandate in recent years, spearheading the highly ambitious national campaign to expand universal health insurance to the entire Moroccan population. In a wide-ranging and in-depth conversation, CNSS Director General Hassan Boubrik lays out the scope and scale of…

UAE Cleveland Clinic Abu Dhabi ranks as the UAE’s best hospital, in the top 150 globally, and recently opened a new comprehensive state-of-the-art cancer centre. CEO Dr Jorge A. Guzman outlines how the hospital’s focus on providing complex, quality, patient-centric care is a key differentiator, its role in raising standards of…

Spain The latest news from Spanish pharmaceuticals and healthcare, including national champion Esteve’s decision to sell of a quarter of its stock to German private investment firm Lubea; news of pharma’s increased weighting in Spain’s exports for 2022; and why – bolstered by EU recovery funds – the country has a…

Greece After 15 years of economic struggles coupled with political swings to the left and right, Greece seems to be on its surest footing in decades. Indeed, the Economist observed that the May 2023 election victory of incumbent Greek Prime Minister Kyriakos Mitsotakis (and the heavy defeat handed to his left…

Belgium Karel van de Sompel of GIBBIS – the pluralistic federation of the public and private social-profit healthcare sector within the Brussels area – outlines the scope and aims of the organisation, the learnings from his near-four decades at Pfizer that can be applied in this new role, and some of…

Greece Country managers from three leading medtech multinationals give their take on the key access challenges facing medical device companies in Greece.   New Access Models “While some value-based procurement agreements have been struck in the private sector, we are struggling to gain acceptance for such agreements in the public sector.…

UAE An overview of the evolution of healthcare infrastructure, professionals, and spending in Dubai. Taken from the Dubai Health Authority’s Investment Guide 2023, the below charts show the rapid growth of the healthcare ecosystem in the Emirate and hint at its future prospects for further development.   made with Visme Infographic…

Greece Greek medtech industry veteran Dimitris Nikas outlines what makes him optimistic about the future of Greek healthcare, highlights the areas for systemic improvement and how EU recovery funding could help, and explains Greece’s relevance to Medtronic as an increasingly open early launch market for some of its most innovative new…

Belgium Luc Van Gorp is president of the Christian Mutuality, Belgium’s largest health insurance fund. In a wide-ranging recent conversation with PharmaBoardroom, Van Gorp expanded on some of the key themes in his 2021 book ‘Human Scale: A Plea for Imperfection’ (‘Mensenmaat: Een Pleidooi Voor Imperfectie’ in Dutch), including why innovation…